Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Inmune Bio (INMB) Leases (2019 - 2025)

Inmune Bio's Leases history spans 7 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Leases rose 217.61% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $1.1 million, up 217.61%, while the annual FY2024 figure was $307000.0, 25.85% down from the prior year.
  • Leases for Q3 2025 was $1.1 million at Inmune Bio, up from $374000.0 in the prior quarter.
  • Across five years, Leases topped out at $1.1 million in Q3 2025 and bottomed at $128000.0 in Q3 2021.
  • The 5-year median for Leases is $414000.0 (2023), against an average of $443473.7.
  • The largest YoY upside for Leases was 374.45% in 2022 against a maximum downside of 30.17% in 2022.
  • A 5-year view of Leases shows it stood at $726000.0 in 2021, then tumbled by 30.17% to $507000.0 in 2022, then dropped by 18.34% to $414000.0 in 2023, then dropped by 25.85% to $307000.0 in 2024, then soared by 246.58% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for INMB's Leases are $1.1 million (Q3 2025), $374000.0 (Q2 2025), and $278000.0 (Q1 2025).